Lv41
424 积分 2025-11-07 加入
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
10小时前
已完结
Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial
18天前
已完结
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer
20天前
已完结
Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers
26天前
已完结
Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer
26天前
已完结
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
26天前
已完结
Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications
26天前
已完结
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
28天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
4个月前
已完结
Induction Toripalimab and Chemotherapy for Organ Preservation in Locally Advanced Laryngeal and Hypopharyngeal Cancer: A Single-Arm Phase II Clinical Trial
4个月前
已完结
皖公网安备34019202002308
